Crinetics Pharmaceuticals, Inc. (CRNX)

43.44 -0.56 (-1.27%) USD  |  NASDAQ  |  Feb 20, 16:00
43.44 0.00 (0.00%) After-Hours: 20:00
More

Crinetics Pharmaceuticals Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for CRNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. Upgrade
GT Biopharma, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
Sutro Biopharma, Inc. Upgrade
Gossamer Bio, Inc. Upgrade